These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11822245)

  • 81. Drug-use evaluation of thrombolytic agents: a challenge to pharmacists.
    Green JA
    Am J Hosp Pharm; 1988 Oct; 45(10):2192-4. PubMed ID: 3228086
    [No Abstract]   [Full Text] [Related]  

  • 82. Hospitals vigilant for quality in pharmacy.
    Perry PA
    Hosp Mater Manage; 1989 Dec; 14(12):1-2. PubMed ID: 10296163
    [No Abstract]   [Full Text] [Related]  

  • 83. Formulary system versus formulary, "the book".
    Habeger HE
    Am J Hosp Pharm; 1987 Sep; 44(9):2030. PubMed ID: 3674036
    [No Abstract]   [Full Text] [Related]  

  • 84. Do P&T committees have enough power? Plans and PBMs are divided about sharing drug prices with clinicians. Is it better to have an administrative committee determine the formulary?
    Cross M
    Manag Care; 2007 Apr; 16(4):39-42. PubMed ID: 17491288
    [No Abstract]   [Full Text] [Related]  

  • 85. Computer assistance for the P&T committee.
    Gurtel AL; Fallavollita A; Rockey PH; Gleser M
    Am J Hosp Pharm; 1980 Oct; 37(10):1305. PubMed ID: 7424922
    [No Abstract]   [Full Text] [Related]  

  • 86. Increasing stakes and complex dynamics in the formulary process.
    Tadlock C
    Manag Care Interface; 2007 Mar; 20(3):12, 14. PubMed ID: 17458473
    [No Abstract]   [Full Text] [Related]  

  • 87. Policy and Procedure Manual. Processing nonformulary drug requests.
    Curr Concepts Hosp Pharm Manage; 1987; 9(4):20-1. PubMed ID: 10284439
    [No Abstract]   [Full Text] [Related]  

  • 88. Development and implementation of a P&T committee for state institutions.
    Gourley DR; Halbert MR; Hartmann KM; Malone PM
    Hosp Formul; 1981 Feb; 16(2):143-4, 149-51, 154-5. PubMed ID: 10250214
    [No Abstract]   [Full Text] [Related]  

  • 89. ASHP guidelines for hospital formularies.
    Am J Hosp Pharm; 1978 Mar; 35(3):326-8. PubMed ID: 626216
    [No Abstract]   [Full Text] [Related]  

  • 90. How we make our hospital formulary work effectively.
    Burns D
    Pharm Times; 1985 Jun; 51(6):98, 100-1. PubMed ID: 10271653
    [No Abstract]   [Full Text] [Related]  

  • 91. Analysis of hospital formulary effects on cost control.
    Daniels CE; Wertheimer AI
    Top Hosp Pharm Manage; 1982 Aug; 2(2):32-49. PubMed ID: 10313966
    [No Abstract]   [Full Text] [Related]  

  • 92. ASHP technical assistance bulletin on hospital formularies.
    Am J Hosp Pharm; 1985 Feb; 42(2):375-7. PubMed ID: 3976687
    [No Abstract]   [Full Text] [Related]  

  • 93. A survey of drug formulary procedures in Naval Hospitals and the feasibility of change.
    Lucas JR; Winship HW
    Mil Med; 1976 Jan; 141(1):13-20. PubMed ID: 814484
    [No Abstract]   [Full Text] [Related]  

  • 94. The evolutionary role of the pharmacy and therapeutics committee in technology assessment.
    Mehr SR
    Manag Care Interface; 2006 Jan; 19(1):42-5. PubMed ID: 16453995
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Guidelines for therapeutic interchange-2004.
    Gray T; Bertch K; Galt K; Gonyeau M; Karpiuk E; Oyen L; Sudekum MJ; Vermeulen LC;
    Pharmacotherapy; 2005 Nov; 25(11):1666-80. PubMed ID: 16232030
    [No Abstract]   [Full Text] [Related]  

  • 96. Formularies: principles, problems, and prognosis.
    Rucker TD
    Hosp Pharm; 1982 Sep; 17(9):460-1. PubMed ID: 10257550
    [No Abstract]   [Full Text] [Related]  

  • 97. Rethinking the formulary system concept. Introduction.
    Zellmer WA
    Am J Hosp Pharm; 1986 Nov; 43(11):2829. PubMed ID: 3799621
    [No Abstract]   [Full Text] [Related]  

  • 98. Perspectives on the hospital formulary.
    Hoffmann RP
    Hosp Pharm; 1984 May; 19(5):359-61, 364. PubMed ID: 10266244
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Getting ahead of the Pharmacy and Therapeutics Committee learning curve.
    Tadlock C
    Manag Care Interface; 2007 Jul; 20(7):12. PubMed ID: 17849726
    [No Abstract]   [Full Text] [Related]  

  • 100. The future of drug product selection in health care and the role of the pharmacy and therapeutics committee.
    Cohen P
    Manag Care Interface; 2006 Dec; 19(12):15-6. PubMed ID: 17274477
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.